The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

CropLogic Limited has announced the increase in its industrial hemp trial farm in Oregon, USA.

This increase will see Industrial Hemp move from 150 to 500 acres to further integrate its agronomy, study of crops and soils, and agtech expertise.

It will also allow for its subsidiary, LogicalCropping, to evaluate data for different growing conditions such as soil type, land contours and elevation to optimise crop yields.

CropLogic will use drones, aerial imagery and grower view to apply its agronomy expertise. Total production is estimated to be between 800,000 and 1,100,000 pounds of industrial hemp across the 500 acres.

CropLogic CEO James Cooper-Jones hopes the production will keep increasing.

“We feel the varying growing environments presents an opportunity for CropLogic to further vertically integrate its agronomy and agtech expertise,” he said.

Industrial hemp is used for any industrial (non-drug) use such as fabrics, biodegradable plastics, construction, health food and fuel.

With this trial CropLogic will also release 75,000,000 shares to sophisticated and institutional investors to raise $3 million at $0.04 per share.

It will be undertaken in two phases with the first one to release 42,490,411 shares and raise $1.7 million. The second phase consists of 31,509,589 shares to raise $1.3 million but will be subject to approval at the next general meeting in May 2019.

Please find the announcement here

CLI by the numbers
More From The Market Online

Market shrugs as Fisher & Paykel announces mass recall

Fisher & Paykel has initiated a voluntary limited recall of batches of Airvo 1 and my…
The Market Online Video

Brian Leedman’s BlinkLab to join ASX: AI-driven smartphone app screens for autism, ADHD

BlinkLab is a world-first, AI-driven digital healthcare venture, that uses a smartphone and facial recognition to…

Osteopore stock spikes 900% on Singapore and Vietnam approvals

Osteopore's (ASX:OSX) share price was up 38% after the regenerative medicine company received approval for its…

Amplia Therapeutics takes step up in pancreatic cancer treatment

Amplia Therapeutics is on to next step in its pancreatic cancer treatment research after a successful…